Depression Risk Lower With GLP-1 Receptor Agonists Versus DPP-4 Inhibitors in Seniors
Modestly lower risk for depression seen compared with DPP-4i use, but not compared with SGLT-2i use
Epidural Steroid Injections Reviewed for Radicular Pain, Spinal Stenosis
Some evidence seen for ESIs reducing pain and disability in cervical and lumbar radiculopathies and possibly in lumbar spinal stenosis
Acalabrutinib-Venetoclax Prolongs Survival in Previously Untreated Leukemia
Progression-free survival significantly lower with fixed-duration acalabrutinib-venetoclax with or without obinutuzumab
Olpasiran Leads to Significant Reduction in Oxidized Phospholipids
Olpasiran leads to significant and sustained reduction in OxPL on apolipoprotein B
Certain Glucose-Lowering Meds Associated With Lower Risk for COPD Exacerbations
Lower risk for COPD exacerbations seen with SGLT-2 inhibitors and GLP-1 receptor agonists, but not with DPP-4 inhibitors
Anifrolumab Tied to Less Organ Damage for Patients With Lupus
Lower likelihood seen for experiencing increase in Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index
Talazoparib + Enzalutamide Tied to Improved Overall Survival in Metastatic Prostate Cancer
Talazoparib + enzalutamide linked to improved survival for patients with mCRPC unselected for HRR gene alterations
De-Escalating DAPT to Ticagrelor Monotherapy Cuts Bleeding Risk in Acute Coronary Syndrome
Lower risk for bleeding without increase in ischemic events seen for patients with acute coronary syndrome
FDA Approves First Rapid-Acting Insulin Biosimilar for Patients With Diabetes
Merilog administered subcutaneously five to 10 minutes before mealtime helps improve glycemic control
Benzoyl Peroxide Formulation Characteristics Explain Variation in Benzene Levels
Leave-on products linked to lower concentrations of benzene; increased concentrations seen in conditions consistent with hot processing
